Compare BTCS & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTCS | TMCI |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.5M | 120.4M |
| IPO Year | 2008 | 2021 |
| Metric | BTCS | TMCI |
|---|---|---|
| Price | $1.17 | $4.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $5.00 | $4.77 |
| AVG Volume (30 Days) | ★ 654.6K | 612.4K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $16,491,584.00 | ★ $212,690,000.00 |
| Revenue This Year | $21.23 | N/A |
| Revenue Next Year | N/A | $8.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 304.85 | 1.59 |
| 52 Week Low | $1.15 | $1.17 |
| 52 Week High | $8.49 | $7.78 |
| Indicator | BTCS | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 27.92 | 79.10 |
| Support Level | N/A | $2.46 |
| Resistance Level | $1.98 | $7.08 |
| Average True Range (ATR) | 0.11 | 0.24 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 0.79 | 100.00 |
BTCS Inc. ("BTCS" or the "Company"), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ("DeFi") and traditional finance ("TradFi") mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.